发明名称 (4-chloro-2-fluoro-N-(2-fluorophenyl)-5-[(8aR)-hexahydropyrrolo-[1,2-a]pyrazin-2(1H)-ylcarbonyl]-benzenesulfonamide, and pharmaceutically acceptable salts thereof
摘要 The present application relates to calcium channel inhibitors comprising compounds of formula (I), formula (II), formula (III), or formula (IV),; wherein L1, R1, R2, R3, R4, R5, R6, R7 and Rc are as defined in the specification. The present application also relates to compositions comprising such compounds, and methods of treating conditions and disorders using such compounds and compositions.
申请公布号 US8741899(B2) 申请公布日期 2014.06.03
申请号 US201313758615 申请日期 2013.02.04
申请人 AbbVie Inc. 发明人 Zhang Qingwei;Stewart Andrew O.;Xia Zhiren
分类号 A61K31/495 主分类号 A61K31/495
代理机构 代理人
主权项 1. A compound that is 4-chloro-2-fluoro-N-(2-fluorophenyl)-5-[(8aR)-hexahydropyrrolo[1,2-a]pyrazin-2(1H)-ylcarbonyl]-benzenesulfonamide, or a pharmaceutically acceptable salt thereof.
地址 North Chicago IL US